The “Cell and Advanced Therapies Supply Chain Management Market, 2020-2030” report -<Roots Analysis>
Toorder this 510+ page report, please visit this - https://www.rootsanalysis.com/reports/view_document/cell-therapies-supply-chain/260.html
Key Inclusions
§ An insightful companycompetitiveness analysis, taking into consideration the supplier power (basedon their employee base and years of experience in the industry) andportfolio-related parameters, such as number of software solutions offered,affiliated modes of deployment, scale of management, end users, applications,regulatory certifications / accreditations, support services offered, and keyplatform specifications and benefits.
§ Comprehensiveprofiles of industry players that are currently offering software solutions forsupply chain management, featuring an overview of the company, its financialinformation (if available), and adetailed description of its software system(s). Each profile also includes alist of recent developments, highlighting the key achievements, partnershipactivity, and the likely strategies that may be adopted by these players tofuel growth, in the foreseen future.
§ A detailed review ofthe cell and advanced therapies supply chain, offering insights on theprocesses associated with various stages, such as donor eligibility assessment,sample collection, manufacturing, logistics, and patient verification andtreatment follow-up, along with information on cost requirements and existingopportunities for improvement in the supply chain management practices.
§ A qualitativeassessment of the current and long-term needs of different stakeholders(patients, healthcare providers, collection centers, manufacturers, logisticsservice providers and regulators / payers) involved in the cell and advancedtherapies supply chain, featuring a summary of the diverse needs and areas ofconcern, along with our opinion (based onpast and prevalent trends) on how the industry is preparing to address suchissues.
§ An analysis of theinvestments made at various stages of development, such as seed financing,venture capital financing, debt financing, grants, capital raised from IPOs andsubsequent offerings received by companies that are engaged in this field.
§ An analysis of thepartnerships that have been established in the domain, in the period between2014 and Q3 2019, covering software licensing agreements, mergers andacquisitions, product development agreements, product integration agreements,distribution agreements, asset purchase agreements, and other relevant deals.
§ A detailed analysisof the platform utilization use cases where aforementioned software systemswere leveraged by various stakeholders in the domain, in the period between2014 and Q3 2019, highlighting the ways in which companies have implementedsuch systems to improve / optimize various supply chain-related processes ofcell and advanced therapies.
§ An in-depth analysisof the cost saving potential across various processes of the cell and advancedtherapies supply chain that can be brought about by the implementation ofbespoke and integrated technological solutions / software systems.
The USD 1.5 billion (by 2030) financial opportunitywithin the cell and advanced therapies supply chain management market has been analysed across the following segments:
§ Application area
§ Sample collection andprocessing
§ Manufacturing
§ Logistics
§ Patientidentification and treatment follow-up
§ Type of softwaresolution
§ Cell orchestrationplatform
§ Enterprisemanufacturing system
§ Inventory managementsystem
§ Laboratoryinformation management system
§ Logistics managementsystem
§ Patient managementsystem
§ Quality managementsystem
§ Mode of Deployment
§ Cloud-based solution
§ On-premises solution
§ Scale of Operation
§ Clinical
§ Commercial
§ End user
§ Biobank
§ Cell therapy lab /commercial organization
§ Hospital / medicalcenter
§ Research institute
§ Key geographicalregions
§ North America
§ Europe
§ Asia Pacific
§ Rest of the world
Torequest a sample pages, please visit this - https://www.rootsanalysis.com/reports/260/request-sample.html
Key Questions Answered
§ What are the trendingsoftware solutions for the management of cell and advanced therapies supplychain?
§ Whoare the leading industry and non-industry players in this domain?
§ What are the keychallenges faced by various stakeholders in this domain?
§ Whatkind of partnership models are commonly adopted by stakeholders in thisindustry?
§ Whoare the key investors in this field?
§ Whatis the current and likely future cost saving opportunities associated withsupply chain management solutions?
§ Howis the current and future market opportunity likely to be distributed acrosskey market segments and geographies?
§ What factors arelikely to influence the evolution of this upcoming market?
Youmay also be interested in the following titles:
1. Global T-Cell (CAR-T, TCR, and TIL) Therapy Market (4th Edition), 2019 – 2030
2. Stem Cell Therapy Contract Manufacturing Market, 2019-2030
3. Cell and Gene Therapy CROs Market, 2018-2030
Contact:
GauravChaudhary
+1(415) 800 3415
